共 33 条
[1]
Aguirre MA, 2002, J RHEUMATOL, V29, P1793
[2]
[Anonymous], 2018, VIDAL FRENCH DRUG DA
[4]
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study
[J].
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY,
2017, 31 (10)
:1693-1699
[8]
Colson MH, 2012, ADV SEX MED, V2, P10